Cases 21 - 30 of 45
Cipla Limited et al v. AstraZeneca AB et al
as 1:2019cv00438
Defendant:
AstraZeneca AB, Aktiebolaget Hassle, AstraZeneca Pharmaceuticals LP and others
Plaintiff:
Cipla Limited and Cipla USA, Inc.
Cause Of Action: 28 U.S.C. § 2201
Genentech, Inc. et al v. InvaGen Pharmaceuticals, Inc., et al.
as 1:2019cv00219
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Defendant:
Cipla Limited, InvaGen Pharmaceuticals, Inc. and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Cipla Ltd. et al v. Amgen Inc.
as 1:2019cv00044
Defendant:
Amgen Inc. and Teva Pharmaceuticals USA, Inc.
Plaintiff:
Cipla USA, Inc. and Cipla Ltd.
Cause Of Action: 15 U.S.C. § 1
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Cipla Limited et al
as 1:2018cv01789
Defendant:
Cipla USA, Inc. and Cipla Limited
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. v. Ascent Pharmaceuticals, Inc. et al
as 1:2018cv01673
Defendant:
Cipla Limited, Perrigo Company plc, Taro Pharmaceuticals U.S.A., Inc. and others
Plaintiff:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Cipla Limited et al
as 1:2018cv00753
Plaintiff:
H. Lundbeck A/S , Takeda Pharmaceutical Company Ltd. , Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Cipla Limited and Cipla USA Inc.
Counter_claimant:
Cipla Limited and Cipla USA Inc.
Counter_defendant:
H. Lundbeck A/S , Takeda Pharmaceutical Company Ltd. , Takeda Pharmaceuticals America, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Onyx Therapeutics, Inc. v. CIPLA Limited et al
as 1:2018cv00598
Plaintiff:
Onyx Therapeutics, Inc.
Defendant:
CIPLA Limited and CIPLA USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Cipla Limited et al
as 1:2018cv00247
Plaintiff:
Pharmacyclics LLC and Janssen Biotech, Inc.
Defendant:
Cipla Limited and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Sandoz Inc. et al
as 1:2018cv00192
Defendant:
Fresenius Kabi Oncology Limited, Fresenius Kabi USA, Inc., Fresenius Kabi USA, LLC and others
Plaintiff:
Pharmacyclics LLC and Janssen Biotech Inc.
Counter Claimant:
Cipla USA Inc., Lek Pharmaceuticals d.d., Cadila Healthcare Limited and others
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Cipla Limited et al
as 1:2018cv00147
Plaintiff:
H. Lundbeck A/S , Takeda Pharmaceutical Company Ltd. , Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Cipla Limited and Cipla USA Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
